Related by context. All words. (Click for frequent words.) 66 modulate ion channels 65 ionotropic glutamate receptor antagonists 64 selectively induce apoptosis 62 Presently DARA 62 PORxin TM 61 carcinoid syndrome diabetes 60 Micromet proprietary BiTE 60 muscarinic receptor agonist 60 GPCR targets 60 THR beta agonist 60 preclinical xenograft models 60 fusion enhancers 60 chemoattractant receptors 60 pipeline GlycoPEG GCSF 60 Adnectin 59 MAbs targeting 59 Combivir Kivexa 59 Accelerated Intelligent 59 protein kinase inhibitor 59 OMP #M# 59 kidney urologic 59 histone deacetylase HDAC 59 proprietary LNA 59 Locked Nucleic Acid LNA 59 HepDirect R 59 BioMAP ® Systems 59 Phylomer ® 59 CYT# vascular disrupting 59 sapacitabine CYC# 59 Selzentry Celsentri 59 Panzem NCD 58 gastro intestinal inflammation 58 neurodegenerative diseases Alzheimer disease 58 ImmunoVEX 58 rxRNA TM compounds 58 Epothilones 58 insomnia migraine headaches 58 polyketides 58 rxRNA 58 cardiometabolic disorders 58 ASONEP TM 58 Incretin mimetics 58 MCSP respectively 58 targeted radiotherapeutic 58 therapeutic monoclonal antibody 58 NEUGENE 58 Cobalamin TM mediated 58 enzyme metabolizes 58 lymphoid tumors 58 NuMimetic TM 58 HCV antiviral 58 TRIOLEX HE# 58 Smac mimetic 58 HIV integrase inhibitors 58 Dyax phage display 58 MEK inhibitors 58 MTP inhibitor 58 bioengineered novel 58 immunological diseases 58 CYT# potent vascular disrupting 58 multitargeted 57 Nanobodies 57 Smac mimetics 57 anionic backbone 57 DOS# 57 integrative pharmacology 57 antiangiogenesis therapies 57 immunotherapeutic approaches 57 molecular biomarkers 57 siRNA compounds 57 Nanobodies ® 57 Exelixis compounds 57 muscarinic receptor agonists 57 IMiDs R 57 novel peptide 57 carbohydrate polymer 57 Nanobody ® 57 reverse transcriptase inhibitors 57 cyclophilin inhibitors 57 recombinant antibodies 57 Idera Pharmaceuticals develops 57 adrenergic regulation 57 anticancer therapeutics 57 aptamer therapeutics 57 microtubule inhibitor 57 Drug Discovery AIDD 57 Stapled Peptide 57 alkylating 57 potent recombinant 57 myeloproliferative neoplasms MPNs 56 TG# [003] 56 Nanobody 56 nucleoside analogs 56 siRNA sequences 56 ribonucleotide reductase clinically validated 56 angina nausea 56 monoclonal antibody MAb 56 Anticalins R 56 unique PER.C6 56 phage display libraries 56 including eniluracil ADH 56 tkRNAi technology 56 infectious diseases autoimmune diseases 56 proteasome inhibitors 56 humanized monoclonal antibodies 56 Zemiva TM 56 bioactive carbohydrates 56 Protease inhibitors 56 IMiDs ® 56 M2 subunit 56 therapeutic monoclonal antibodies 56 ENMD # 56 staphylococcal vaccine 56 proteins peptides 56 Synavive ™ 56 Nektar proprietary 56 siRNA therapeutic 56 cleared IND Investigational 56 therapeutic radiopharmaceuticals 56 cytotoxics 56 IMPDH inhibitor 56 morphine fentanyl 56 synthetic anti infective 56 protein kinase inhibitors 56 HepDirect technology 56 novel immunomodulatory 56 hydrophobic docetaxel prodrug nanoparticle 56 psoriasis rheumatoid arthritis 56 anticancer compounds 56 proprietary Isolagen Process 56 Zemiva TM Trofex TM 56 CTLA4 Ig product 56 dAbs 56 Solazed TM 56 Albuferon albinterferon alfa 2b 56 nanomolar potency 56 synthetic peptides 56 Curaxins 56 antimitotic 56 recombinant vaccines 56 Solazed 56 hemorrhagic fever viruses 56 antibiotics antifungals 56 Anticalins 55 molecules peptides 55 VELCADE novel 55 MKC# MT 55 Darapladib 55 CCR5 receptor antagonists 55 scalable PLX PLacental 55 demonstrated anti amnesic 55 loxapine 55 siRNA antisense 55 molecular abnormalities 55 Alexza Staccato 55 Crucell genetically engineered 55 inhibit EGFR 55 regulate therapeutically important 55 injectable investigational 55 Umbilical cord stem cells 55 XL# XL# 55 preclinical compounds 55 hematological diseases 55 anticoagulant reversing agent 55 infectious diseases autoimmune 55 Monoclonal antibodies 55 Prodarsan R 55 protein receptors lectins 55 protein tyrosine phosphatases 55 orally administered inhibitor 55 mediated autoimmune diseases 55 selective orally bioavailable 55 tumor subtypes 55 antibacterial antiviral 55 inflammation autoimmune diseases 55 potent inhibitors 55 nanoviricide drug 55 rheumatoid arthritis multiple sclerosis 55 TRAIL receptor antibodies 55 novel antiviral therapeutics 55 acetylgalactosamine 6 55 small molecule activators 55 Aganocide 55 rxRNA compounds 55 NNR Therapeutics 55 molecules Immune SIMULATORS 55 molecular imaging radiopharmaceuticals 55 selective antagonists 55 OXIGON TM 55 TRIOLEX ™ 55 pandemic influenza strains 55 eligen R technology 55 Sphingomab 55 IMA# 55 TLR8 agonist 55 iSONEP TM 55 Sanofi Pasteur ALVAC canary 55 nitric oxide donating 54 ZFP Therapeutics 54 rheumatoid arthritis inflammatory bowel 54 PLX MS 54 commercializing anti infective 54 proteasome inhibitor 54 DermaVir Patch 54 ESBA# 54 AVI antisense 54 siRNAs targeting 54 Prednisporin 54 Amgen discovers develops manufactures 54 intranasal formulation 54 Kinase inhibitors 54 sulfonylhydrazine class 54 mAbs 54 antagomirs 54 clinically validated targets 54 serine proteases 54 selectively inhibit replication 54 affinity ligands 54 severe degenerative ischemic 54 tubulin inhibitor 54 auristatin 54 rheumatoid arthritis thrombocytopenia 54 rotavirus shingles 54 HCV protease inhibitors 54 selectively inhibit 54 histone deacetylase HDAC inhibitors 54 treating neuropathic pain 54 adrenal steroid hormones 54 Vidaza ® 54 biobetter 54 Transdel TM platform 54 Anticalins ® 54 HPV genotypes 54 Her2 targeting 54 ALS #-# 54 peptide therapeutics 54 Pepducin 54 BioMAP Systems 54 SILENOR TM doxepin HCl 54 lipopeptide 54 Resolvins 54 Panzem R NCD 54 Parasitic worms 54 diabetes irritable bowel 54 Delta opioid receptor 54 dose Mevacor 54 interferon lambda 54 include VALSTAR TM 54 drug conjugates 54 telomerase inhibitor 54 metaglidasen 54 Oral NKTR 54 arthritis psoriasis 54 selective kinase inhibitor 54 Protectans 54 delta opioid receptor 54 nephrology oncology supportive 54 Company novel nanoviricide 54 XL# XL# XL# XL# 54 peptidic 54 DNA methylation biomarkers 54 eXpanded cell product 54 SinuNase ™ 54 TLR8 54 myasthenia gravis Huntington 54 XL# anticancer compounds 54 oral prodrug 54 activate SIRT1 54 anti secretory 54 PDE# inhibitors 54 enhance ApoA 54 LHRH antagonists 54 antibiofilm 54 RNAi therapeutic targeting 54 commercializes implantable 54 small molecule glucokinase 54 Pimavanserin 54 autoimmune uveitis 54 IAP inhibitors 54 antisense compounds 54 indications Cytokinetics 54 echinocandins 54 treats acute lymphoblastic 54 HCV polymerase 54 inhibit metastasis 54 miRNA molecules 54 molecularly targeted therapies 54 recombinant antibody 54 genomic variants 54 biomarkers predictive 54 selective inhibitors 53 silicon carbide SiC gallium 53 PNP inhibitor 53 proprietary MSCRAMM protein 53 AMPK activators 53 therapeutic mAbs 53 REMOXY POSIDUR ELADUR 53 nucleosides 53 rheumatoid arthritis lupus 53 PI3K/Akt pathway inhibitor 53 Pancreate 53 isotypes 53 epithelial tumors 53 Kosan dependence 53 nanomolar 53 include GALNS N 53 macrocycles 53 TRIOLEX TM HE# 53 chemogenomics 53 oncolytic virus therapies 53 CEA CD# Her2 53 potent antiproliferative 53 molecularly targeted 53 curative therapies 53 gastrointestinal infectious 53 drugs cough suppressant 53 genomics proteomics biosensors 53 intracellular protein 53 KRAS oncogene 53 biologic therapeutics 53 peptides proteins 53 oncolytic 53 nucleoside analogues 53 vaccine adjuvant 53 HCV polymerase inhibitors 53 5 HT2A serotonin 53 nanoviricides 53 antisense inhibitors 53 histocompatibility 53 immune modulating 53 antitumour 53 benzimidazole 53 CytRx oncology 53 splice variants 53 Deforolimus 53 ALN PCS 53 orally bioavailable 53 monoclonals 53 Sustiva efavirenz 53 EHT AGN 53 neuropsychiatric diseases 53 LNP formulations 53 Pharmos pipeline 53 commercial bioproduction 53 Panzem R 53 MAbs 53 fatty acid biosynthesis 53 antifungal agents 53 Ostabolin C TM 53 epigenetic therapeutics 53 DGAT1 inhibitors 53 susceptibility loci 53 JAK2 inhibitor 53 antifungal compounds 53 XmAb ® 53 intranasal insulin product 53 Locked Nucleic Acid 53 renin inhibitors 53 CFTR corrector 53 cardio renal 53 NS#/#A protease 53 MKC# MKC# PP 53 BioSilicon ™ 53 Speedel develops 53 BRAF kinase 53 Annamycin 53 Tarvacin Anti Viral 53 Ridaforolimus 53 GPR# agonist 53 hematological tumor 53 capsular polysaccharide 53 Nanobody R 53 deCODE AF TM 53 RNA antagonist 53 HepDirect prodrug 53 short hairpin RNAs 53 anticancer therapies 53 multiple sclerosis rheumatoid arthritis 53 ChronVac C R 53 Rigel R# 53 therapies ACTs 53 personalized immunotherapy 53 telomerase activators 53 antiviral compounds 53 GATTEX teduglutide 53 AZT zidovudine 53 cytotoxic agents 53 potently inhibit 53 targeted biologic therapies 53 polymerase inhibitors 53 next generation URAT1 53 antiviral antibacterial 52 DPIV inhibitors 52 ADME properties 52 nucleotide analogues 52 Evoltra ® 52 missense mutations 52 proliferative diseases 52 ETBs 52 virus HCV protease inhibitor 52 Therapies SRT 52 synthetic cannabinoid compounds 52 syndrome carcinoid syndrome 52 anti epileptics 52 systemic RNAi therapeutic 52 hematologic oncology 52 Therapeutic antibodies 52 peptide ligands 52 ErbB3 HER3 52 AN# novel 52 neuroprotective properties 52 IL# PE 52 Xcytrin R 52 therapeutic peptide 52 reversible inhibitor 52 OvaRex R 52 topical dermatology 52 anti amnesic 52 immunotherapeutics 52 MVA BN R 52 resultant PLX PLacental eXpanded 52 FUSILEV enhances 52 surface proteins hemagglutinin 52 EndoTAG 52 Delafloxacin 52 biomarker identification 52 anti angiogenic drugs 52 Squalamine 52 rendering Cytokinetics 52 Zalypsis 52 CD# CEA 52 muscular dystrophy cystic fibrosis 52 p# inhibitor 52 Aganocide ® 52 efavirenz Sustiva 52 JAK2 inhibitors 52 prognostic markers 52 CB2 selective 52 anti fungals 52 deforolimus 52 novel immunotherapies 52 ALK inhibitors 52 NITD# 52 immunotherapeutic 52 lipid nanoparticle 52 genomic biomarkers 52 liposomal formulations 52 artemisinin derivative 52 novel anti infective 52 noninvasive prenatal testing 52 mda 7 52 foods insect stings 52 painkiller Valium 52 preclinically 52 Xanafide 52 DG# compounds targeting 52 Genetic variations 52 antimicrobial compounds 52 vitamins minerals herbal 52 ALN TTR 52 diuretics antibiotics 52 mTOR inhibitors 52 molecular imaging radiopharmaceutical 52 Archexin 52 Zolinza 52 fluconazole resistant 52 RNAi reagents 52 Onconase 52 cytomegalovirus infections 52 GLPG# 52 TOCOSOL 52 Multiple Sclerosis Rheumatoid Arthritis 52 ViroChem 52 radiation chemoradiation 52 preferentially bind 52 TLR9 agonists 52 neuro degenerative disorders 52 sulfonylurea glimepiride 52 neuronal nicotinic receptors NNRs 52 colorectal bladder 52 Protein Kinase C 52 xenograft models 52 Tß4 52 breast cancer subtypes 52 OMP #R# 52 Cloretazine 52 discodermolide 52 small molecule 52 multiple sclerosis lupus 52 CCR5 inhibitors 52 selective androgen receptor modulators 52 RAF kinase 52 Bcr Abl mutations 52 tolevamer 52 multiplex assay 52 antigenic fingerprint 52 Panzem 52 Amgen Kyowa Hakko Kirin 52 CFTR inhibitors 52 peptide antigens 52 enzyme inhibitor 52 K ras mutations 52 genomic proteomic 52 paclitaxel Taxol ® 52 vitamin D analogs 52 Personalized Immunotherapy 52 anemias 52 ASG 5ME 52 antisense drug 52 ATL# [002] 52 Receptors GPCRs 52 Cyclosert 52 GABA aminotransferase inhibitor 52 TBC# 52 Angiocept 52 CD8 + cytotoxic 52 peptide sequences 52 infectious autoimmune 52 basal cell carcinoma squamous 52 ritonavir boosted protease inhibitor 52 fluorescent pigments 52 chimeric monoclonal antibody 52 ALN TTR# 52 genetic loci 52 MediGene focuses 51 inflammatory autoimmune diseases 51 generation siRNA sequences 51 PI3K inhibitors 51 relapsed leukemia 51 Anticalin 51 highly selective endothelin 51 XmAb 51 highly selective inhibitor 51 investigational compounds 51 CDDO Im 51 inhibit replication 51 synthetic siRNA 51 synthetic retinoid 51 tumor xenograft models 51 sorafenib Nexavar R 51 enabled ARIUS 51 circulating endothelial cells 51 tropical parasitic 51 radiolabeled antibodies 51 cleavable linker 51 enterotypes 51 adipiplon 51 pan genotypic 51 topical antifungal 51 CTL epitopes 51 FOLFOX6 chemotherapy regimen 51 GPR# agonists 51 Affilin ® 51 PI3K AKT 51 anti CD# antibodies 51 histone deacetylase 51 AEG# 51 validating biomarkers 51 taxane derivative 51 Skinvisible receives 51 prostone 51 chemotherapeutic regimens 51 glycosylation profile 51 SERMs 51 therapeutic modalities 51 ZFPs 51 ALV# 51 VDAs 51 histologies 51 vaccine GRNVAC1 51 conventional chemotherapies 51 LymphoStat B TM 51 Aurora kinase inhibitor 51 synthetic cannabinoid library 51 therapeutic antibodies 51 PI3K/mTOR 51 sorafenib Nexavar ® 51 PCR primers 51 Prodarsan ® 51 PDE4 inhibitors 51 GSK# [002] 51 glial tumors 51 pharmacologically active isomer 51 Yamanaka recipe 51 therapeutic regimens 51 selective receptor agonist 51 selective estrogen receptor modulator 51 oral proteasome inhibitor 51 sufentanil 51 topical anti infective 51 Buy cheap kamagra 51 cathepsins 51 apply Enhanze technology 51 typhoid tuberculosis 51 ® bortezomib 51 DepoVax ™ 51 dihydrofolate reductase DHFR 51 cardiotoxic effects 51 Daclizumab 51 Innovive Pharmaceuticals 51 siRNA duplexes 51 Myolimus 51 humanin 51 beta interferons 51 cytochrome P# inhibition 51 antiangiogenic agent 51 OncoVEX 51 AKT inhibitor 51 commercializes oncology 51 experimentally validated 51 liposome encapsulated 51 SynCon TM 51 milk thistle extract 51 novel peptide therapeutics 51 genetic susceptibilities 51 Adenoviruses 51 opiates muscle relaxants 51 cynomolgus macaques 51 viral antigens 51 beta lactam 51 lintuzumab SGN 51 asthma COPD Chronic 51 taxane chemotherapy 51 thalidomide Thalomid 51 neuropathic pain nerve 51 CCR9 antagonist 51 platinum chemotherapeutic 51 antibacterial agents 51 Tekamlo 51 immune stimulatory 51 monoclonal antibody therapeutics 51 immuno inflammatory diseases 51 TPI ASM8 51 auristatin E MMAE 51 small molecule agonists 51 SIRT1 activators 51 antisense drugs 51 Pertuzumab 51 novel orally bioavailable 51 resistant mutants 51 chemopreventive agents 51 antisense oligonucleotides 51 oncology metabolic disorders 51 radiation sensitizer 51 anticancer agents 51 carbohydrate polymers 51 novel emulsion formulation 51 cancer immunotherapies 51 adrenoceptor agonist 51 cerebro cardiovascular diseases 51 proprietary attenuated Listeria 51 kinase inhibitors 51 sigma receptors 51 GRN# 51 siRNA therapeutics 51 defensin mimetic antibiotic 51 immunosuppressive regimens 51 lupus multiple sclerosis 51 forodesine hydrochloride 51 progestagen 51 reverse transcriptase inhibitor 51 prodrugs 51 G Protein Coupled 51 #T# tumor 51 candidate iSONEP TM 51 act synergistically 51 romazarit 51 ImmunoGen TAP technology 51 KinomeScan 51 scorpion toxin 51 causative mutations 51 targets TRPM8 51 hormone gastrin 51 Omrix biosurgery product 51 HGS# 51 prolyl hydroxylase inhibitors 51 proprietary phage display 51 beta lactams 51 Tyrima 51 orally dosed 51 commercializing novel biotherapeutics 51 HyperAcute 51 pharmacogenetic tests 51 biomarkers 51 beta lactam antibiotic 51 tetravalent 51 hypermethylated 51 Induced pluripotent stem cells 51 investigational monoclonal antibody 51 brain penetrant 51 Fibroblast Growth Factor Receptor 51 biologically validated targets 51 VentiRx 51 NF kB Decoy 51 immunomodulatory therapy 50 VersaFilm 50 PEGylated 50 including calcitonin PTH 50 isoform selective 50 predictive toxicology 50 humanized antibodies 50 beta secretase inhibitors 50 RELOVAIR ™ 50 mitiglinide 50 aptamer 50 anti angiogenic agents 50 SGLT Inhibitors 50 ocular inflammatory 50 anthrax botulism tuberculosis typhoid 50 Fleximer 50 resistant microorganisms 50 cholesteryl ester transfer 50 humanized antibody 50 chemical entities NCEs 50 Restoraderm R technology 50 Cathepsin S 50 mertansine 50 NanoCrystal Technology 50 #S rRNA gene 50 JAK inhibitor 50 beta lactam antibiotics 50 intranasal delivery 50 OHR/AVR# 50 anthrax botulism typhoid 50 midstage studies 50 lipid nanoparticles 50 RNA antagonists 50 NEUGENE R 50 COPEGUS R 50 selective immunoproteasome inhibitor 50 cefixime 50 drug zotarolimus 50 viral respiratory infections 50 developing TB4 50 irinotecan oxaliplatin 50 neuroscience autoimmune 50 BCR ABL inhibitors 50 targeted anticancer therapies 50 A3 adenosine receptor 50 DsiRNA 50 Pathway Inhibitor 50 alpha pinene 50 Vaxfectin 50 immunotoxin 50 Darinaparsin 50 Nanobodies TM 50 pyrimidines 50 Hsp# inhibitors 50 GAP #B# 50 reuptake inhibitors 50 novel anticancer 50 Onco TCS 50 novel orally administered 50 #HT# 50 systemic antifungal 50 neuroactive 50 Inc. Nasdaq INFI 50 metabonomics 50 RAS MAPK pathway 50 delta isoform 50 MSCRAMM R 50 genetic aberrations 50 Enbrel rheumatoid arthritis 50 oral talactoferrin 50 macular degeneration diabetic retinopathy 50 nucleoside analog 50 imexon 50 orphan GPCRs 50 AQD class 50 molecular chaperone regulation 50 fibrate drugs 50 NNRs 50 activate Nrf2 50 small molecule defensin 50 antifolates 50 subcutaneous immunoglobulin 50 lamivudine zidovudine 50 FLT3 50 vosaroxin 50 ibuprofen acetaminophen 50 proven DuraSite ® 50 patient subpopulations 50 Phylomer 50 hypoxia activated prodrug 50 sickle cell cystic fibrosis 50 selectively inhibits 50 CCR5 antagonists 50 aldehyde dehydrogenase ALDH2 deficiency 50 Olaparib 50 mRNA molecules 50 VitiGam TM 50 AGS PSCA 50 metabolomic profiles 50 Biochronomer 50 antibiotic Tygacil 50 chemotypes 50 immunotoxins 50 oral ghrelin agonist 50 LentiVector technology 50 selective inverse agonist 50 Nasulin ™ 50 viral isolates 50 IMC A# 50 targeting abnormally proliferating 50 novel RNAi therapeutics 50 monoclonal antibody therapies 50 identify protein biomarkers 50 Symadex 50 Dicer Substrate Technology 50 NS5B 50 radiotherapeutic 50 antiangiogenic agents 50 Mpex 50 Tesetaxel 50 Benzoyl peroxide 50 antigen antibody 50 neurology infectious 50 Pharmos proprietary 50 TNF alpha antagonist 50 tegafur 50 PDE4 inhibitor 50 exosome 50 PPAR gamma agonists 50 Litx 50 Etubics 50 technology cHTS 50 siRNA binds 50 NXL# 50 beta lactamase inhibitor 50 Vertex hepatitis C 50 patented Bioral R nanocochleate 50 bendamustine ifosfamide 50 Apo2L 50 TLR9 agonist 50 EGFR antibodies 50 regorafenib 50 SARMs 50 predictive biomarkers 50 therapeutics 50 immunologic diseases 50 obatoclax GX# 50 prescription dermatological 50 lumefantrine 50 CORT # 50 deliver innovative biomedicines 50 immuno modulatory 50 OneNeck supports 50 immune suppressive 50 hypoxia selective 50 therapeutics diagnostics 50 MDx tests 50 flavanoid 50 morpholino 50 Prescription acetaminophen 50 HepeX B 50 PNT# 50 tRNA synthetases 50 TLR agonists 50 human influenzas 50 tubulin binding 50 Canvaxin TM 50 radionuclide therapy 50 monogenic 50 isotype 50 EndoTAG TM 50 Lisofylline LSF 50 tumor antigens 50 UltiMAb 50 Akt inhibitor 50 Crizotinib 50 metabolite profiles 50 Spiegelmer 50 alkylating agent 50 protein kinases 50 Azedra 50 pharmacodynamic markers 50 Novartis NVS Snapshot Report 50 Duromist ™ 50 dose proportional pharmacokinetics 50 Notch receptors 50 orally bioavailable mimics 50 recombinant subunit vaccine 50 maturation inhibition 50 chemically modified siRNA 50 Magnetic nanoparticles 50 HuCAL antibody 50 bortezomib Velcade R 49 signal transduction inhibitor 49 intradermal delivery 49 NNRTIs 49 FGFs 49 potent cytotoxic 49 Regado 49 genomic markers 49 modulate ion channel 49 TRPV1 agonist 49 inflammatory dermatoses 49 AtuRNAi 49 Pithiviers factory 49 hA# 49 platforms GVAX 49 small molecule tyrosine 49 clade B 49 nucleotide analog 49 neurology dermatology 49 metabolic dysfunctions 49 histological subtypes 49 selectively inhibited 49 retroviral vectors 49 cognitive enhancer 49 EndoTAGTM 1 49 R#/MEM # 49 gemcitabine Gemzar 49 HQK 49 Catechins 49 autoimmune cardiovascular 49 non nucleoside HCV 49 RhuDex ® 49 gene silencing mechanism 49 CEQ# 49 SAR# [002] 49 COX inhibitors 49 pharmacokinetic interactions 49 Dapagliflozin 49 microRNA molecules 49 p# inhibitors 49 selectively modulate 49 protein misfolding diseases 49 SLx 49 liposomal formulation 49 ophthalmic therapeutics 49 skeletal muscle weakness 49 virulence genes 49 Celator 49 biomarker validation 49 unpartnered 49 Provecta TM 49 antiviral therapies 49 hematological cancers 49 mimetics 49 glaucoma ischemia 49 gefitinib Iressa 49 Ampakine compounds 49 Marqibo TM 49 RNAi therapeutic 49 P#X# antagonist 49 Alferon N 49 REG2 Regado 49 selective serotonin 2C receptor 49 CXCR4 receptor 49 Factor VIIa 49 Insegia 49 gamma amino butyric 49 pharmacologic approaches 49 aluminum hydroxide adjuvant 49 ChemBridge 49 racemic mixture 49 SRT# [002] 49 Pretender Rihanna Umbrella 49 Posiphen TM 49 pharmacotherapies 49 5 HT4 agonist 49 torezolid 49 ELND-#/AZD-# 49 drug monomethyl auristatin 49 Epigenomics proprietary 49 treat gastrointestinal disorders 49 TELINTRA R 49 TLR Therapeutics 49 psychoactive component 49 Te tellurium based 49 M. pneumoniae 49 KIAA# 49 YONDELIS R 49 HSP# inhibitors 49 recombinant biopharmaceutical 49 Treatment Shows Promise 49 selective kinase inhibitors 49 nasal spray formulation 49 paclitaxel Taxol 49 cytotoxin 49 Catabasis 49 genomic loci 49 Parkinson disease Alzheimer disease 49 peroxidase 49 pharmacodynamic profile 49 FOLOTYN ® 49 sitagliptin Januvia 49 VaxImmune 49 cytolytic 49 genomic transcriptomic 49 ActA 49 containing abacavir 49 cardiotoxic 49 kinase inhibition 49 Valproic acid 49 molecular entities NMEs 49 acetaminophen tablets 49 DNA gyrase